Northwestern Mutual Wealth Management
CLDX icon

Northwestern Mutual Wealth Management’s Celldex Therapeutics CLDX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$34 – 3317
2023
Q2 		$34 Buy
+1
New +$34 ﹤0.01% 3299
2022
Q1 		– Sell
-100
Closed -$4K – 3139
2021
Q4 		$4K Hold
100
– – ﹤0.01% 2829
2021
Q3 		$5K Sell
100
-13
-12% -$610 ﹤0.01% 2655
2021
Q2 		$4K Buy
113
+13
+13% +$357 ﹤0.01% 2682
2021
Q1 		$2K Hold
100
– – ﹤0.01% 2588
2020
Q4 		$2K Hold
100
– – ﹤0.01% 2517
2020
Q3 		$1K Hold
100
– – ﹤0.01% 2425
2020
Q2 		$1K Hold
100
– – ﹤0.01% 2269
2020
Q1 		$0 Buy
+100
New +$226 ﹤0.01% 2577
2019
Q2 		– Sell
-112
Closed -$1K – 2524
2019
Q1 		$1K Buy
+112
New +$589 ﹤0.01% 2400
2018
Q1 		– Sell
-33
Closed -$1K – 2217
2017
Q4 		$1K Buy
+33
New +$1.41K ﹤0.01% 2201
2016
Q4 		– Sell
-7
Closed – – 2366
2016
Q3 		$0 Buy
+7
New +$436 ﹤0.01% 2190
2016
Q2 		– Sell
-27
Closed -$2K – 2077
2016
Q1 		$2K Hold
27
– – ﹤0.01% 1872
2015
Q4 		$6K Buy
+27
New +$5.89K ﹤0.01% 1271
2013
Q4 		– Sell
-7
Closed -$4K – 1394
2013
Q3 		$4K Buy
+7
New +$2.4K ﹤0.01% 1042

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Northwestern Mutual Wealth Management's CLDX Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Celldex Therapeutics (CLDX) in Q3 2023, closing a stake of 1 share — an estimated $34 sold.

Northwestern Mutual Wealth Management first reported a position in CLDX in Q3 2013 and held it in 15 quarters. The position peaked at $6K in Q4 2015. 144 funds tracked by Wall St. Rank hold CLDX as of Q3 2023.

  • Northwestern Mutual Wealth Management reported no remaining Celldex Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1 Celldex Therapeutics share in Q3 2023, an estimated $34.
  • Northwestern Mutual Wealth Management first reported a position in Celldex Therapeutics in Q3 2013 and held it in 15 quarters.
  • Northwestern Mutual Wealth Management's Celldex Therapeutics position peaked at $6K in Q4 2015.
  • 144 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.